Notice is hereby given that, on November 14, 2016, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Pistoia Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Eagle Genomics Ltd., Cambridge, UNITED KINGDOM; Stuart Chalk (individual member), Jacksonville, FL; Pharmacelera, Sant Cugat del Valles, SPAIN; Pine Biotech Inc., New Orleans, LA; MEDEXPRIM, Labastide-Beauvoir, FRANCE; Insightomics, Lisbon, PORTUGAL; and Benchling, San Francisco, CA, have been added as parties to this venture.
Also, Hewlett Packard, Palo Alto, CA has withdrawn as a party to this venture.
In addition, an existing member, IP & Science Business of Thomson Reuters, has changed its name to Clarivate Analytics, Philadelphia, PA.
No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Pistoia Alliance, Inc. intends to file additional written notifications disclosing all changes in membership.
On May 28, 2009, Pistoia Alliance, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on July 15, 2009 (74 FR 34364).
The last notification was filed with the Department on August 19, 2016. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on September 20, 2016 (81 FR 64506).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2016-29901 Filed 12-12-16; 8:45 am]
BILLING CODE P